Older man smiling while reviewing eConsent on mobile phone, with YPrime eConsent platform screens showing consent notification and patient sign-in.

eConsent for Clinical Trials. Start Enrollment with Confidence.

Simplify Clinical Trial Enrollment with an Advanced eConsent Platform. 
Computer screen icon displaying pie chart and bar graphs, representing dynamic clinical trial information for clear data visualization and communication

Present
dynamic trial
information

Deliver interactive, multimedia consent content that clearly explains trial requirements, expectations, and risks—supporting truly informed consent.

Icons of computer, tablet, and mobile phone representing patient support across all devices, in any language and at their own pace

Support your
patients on
any device

Enable participants to review and complete electronic consent on mobile, tablet, or desktop devices, in their own language and at their own pace.

Headset and chat bubble icon representing built-in patient support for clinical trials, available whenever assistance is needed

Deliver
immediate,
built-in support

Provide real-time access to assistance during the consent process, reducing delays, minimizing site workload, and preventing incomplete or incorrect submissions.

Regulatory requirements for electronic consent continue to evolve across regions. YPrime’s eConsent platform is designed to support compliant, ethical informed consent across global clinical trials, helping sponsors and CROs remain inspection-ready at every phase of the study.

Secure, encrypted data storage
Complete version history and audit trails
Inspection-ready documentation for regulatory review
Female patient electronically signing a consent document on a smartphone, representing streamlined eConsent in clinical trial technology
Clinician using a tablet to manage electronic consent, ensuring clinical trial data integrity and regulatory compliance
At YPrime, data security is at our core. All data in our platform is encrypted, and every version change is stored for future compliance needs or audits.
– David Wallace, Chief Technology Officer, YPrime

Sources:

1Considerations For Improving Patient Recruitment Into Clinical Trials

Scroll to Top